TipRanks
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market
INDP
Indaptus Therapeutics
RESEARCH TOOLSreports
Want to see INDP full AI Analyst Report?

Indaptus Therapeutics (INDP) Income Statement

579 Followers

Indaptus Therapeutics Income Statement

Last quarter (Q2 2026), Indaptus Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Indaptus Therapeutics's net income was $-1.79M. See Indaptus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 19.83M$ 15.37M$ 16.38M$ 14.91M$ 7.73M
Depreciation and Amortization
$ 0.00$ 735.00$ 1.28K$ 1.78K$ 1.40K
EBITDA
$ -20.85M$ -15.02M$ -15.42M$ -14.32M$ -7.71M
Operating Income
$ -19.83M$ -15.37M$ -16.38M$ -14.91M$ -7.73M
Other Income/Expenses
$ -1.02M$ 343.72K$ 955.00K$ 588.11K$ 17.72K
Pretax Income
$ -20.85M$ -15.02M$ -15.42M$ -14.32M$ -7.71M
Net Income
$ -20.85M$ -15.02M$ -15.42M$ -14.32M$ -7.71M
Per Share Metrics
Basic EPS
$ -21.58$ -44.96$ -51.41$ -48.54$ -52.78
Diluted EPS
$ -21.58$ -44.96$ -51.41$ -48.54$ -52.78
Weighted Average Shares Outstanding
 966.12K 334.13K 300.04K 295.07K 146.09K
Weighted Average Shares Outstanding (Diluted)
 966.12K 334.13K 300.04K 295.07K 146.09K
Currency in USD

Indaptus Therapeutics Earnings and Revenue History